Main content
'Not too late to review cost' of breast cancer drug Kadcyla
The NHS has rejected a drug that can extend lives of women with breast cancer because it is 鈥榯oo expensive鈥�. Jennifer Cozzone head of Health Economics and Pricing at Roche and Mia Rosenblatt from Breast Cancer Campaign discuss.
Duration:
This clip is from
Featured in...
![]()
Health clips
Listen to a selection of clips from recent and upcoming programmes.
More clips from Today
-
![]()
Weight loss jabs from GPs - how will it work?
Duration: 05:01
-
![]()
David Lammy: US-Iran can 'only be dealt with in diplomacy'
Duration: 15:55
-
![]()
Clare Balding's tips for keeping your dog cool in the heat
Duration: 05:09
-
![]()
Is this the end for Iran's nuclear programme?
Duration: 18:55
